Literature DB >> 26372448

No association between ApoE and schizophrenia: Evidence of systematic review and updated meta-analysis.

Thelma Beatriz González-Castro1, Carlos Alfonso Tovilla-Zárate2, Yazmín Hernández-Díaz3, Ana Fresán4, Isela E Juárez-Rojop5, Jorge L Ble-Castillo6, Lilia López-Narváez7, Alma Genis8, Mervyn Manuel Hernández-Alvarado9.   

Abstract

INTRODUCTION: Schizophrenia affects between 0.3% and 2% of the worldwide population. A genetic contribution has been postulated in the development of this disorder. Genes such as ApoE have been implicated in the neurodevelopment associated with schizophrenia in case-control and meta-analysis studies, but the results remain inconclusive. Due to this, the aim of the present study was to explore the association between ApoE and schizophrenia through a meta-analysis.
MATERIAL AND METHODS: We collected all relevant studies by searching PubMed and EBSCO databases. The pooled odds ratios with 95% confidence intervals were calculated to estimate the association. The following models were evaluated: A) ε4 vs ε3, B) ε4 vs ε2, C) ε4 vs ε3+ε2, D) Caucasian population and E) Asian population. Statistical analyses were performed using EPIDAT 3.1 software.
RESULTS: The meta-analyses comprised 28 association studies, which included 4703 controls and 3452 subjects with schizophrenia. A significant protective effect was found for allele ε3 in the Asian population (OR=0.73, 95% CI=0.54-0.98). No significant associations were observed in the other models and populations analyzed.
CONCLUSIONS: Our meta-analysis suggests a protective association between ApoE allele ε3 and schizophrenia in the Asian population.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  ApoE gene; Meta-analysis; Schizophrenia; Systematic review

Mesh:

Substances:

Year:  2015        PMID: 26372448     DOI: 10.1016/j.schres.2015.08.031

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  11 in total

1.  Apolipoprotein E-ε4 allele predicts escalation of psychotic symptoms in late adulthood.

Authors:  Katherine Jonas; Sean Clouston; Kaiqiao Li; Laura J Fochtmann; Todd Lencz; Anil K Malhotra; David Cicero; Greg Perlman; Evelyn J Bromet; Roman Kotov
Journal:  Schizophr Res       Date:  2018-12-21       Impact factor: 4.939

2.  APOE E4 is associated with hyperlipidemia and obesity in elderly schizophrenic patients.

Authors:  Wei Li; Fengju Liu; Rui Liu; Xinmei Zhou; Guanjun Li; Shifu Xiao
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

3.  Low prevalence of lipid metabolism abnormalities in APOE ε2-genotype and male patients 60 years or older with schizophrenia.

Authors:  Chunxia Ban; Qunying Zhang; Jie Feng; Huijuan Li; Qi Qiu; Yuan Tian; Xia Li
Journal:  BMC Psychiatry       Date:  2017-12-12       Impact factor: 3.630

4.  Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders.

Authors:  Viktoria Johansson; Joel Jakobsson; Rebecca G Fortgang; Henrik Zetterberg; Kaj Blennow; Tyrone D Cannon; Christina M Hultman; Lennart Wetterberg; Mikael Landén
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-12-30       Impact factor: 5.270

Review 5.  Putative Survival Advantages in Young Apolipoprotein ɛ4 Carriers are Associated with Increased Neural Stress.

Authors:  Carr J Smith; J Wesson Ashford; Thomas A Perfetti
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

6.  Association between clinical symptoms and apolipoprotein A1 or apolipoprotein B levels is regulated by apolipoprotein E variant rs429358 in patients with chronic schizophrenia.

Authors:  Wenwang Rao; Xiangfei Meng; Keqing Li; Yunshu Zhang; Xiang Yang Zhang
Journal:  Ann Gen Psychiatry       Date:  2021-12-20       Impact factor: 3.455

7.  Development of a Melting Curve-Based Allele-Specific PCR of Apolipoprotein E (APOE) Genotyping Method for Genomic DNA, Guthrie Blood Spot, and Whole Blood.

Authors:  Chia-Hsiang Chen
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

Review 8.  The role of C957T, TaqI and Ser311Cys polymorphisms of the DRD2 gene in schizophrenia: systematic review and meta-analysis.

Authors:  Thelma Beatriz González-Castro; Yazmín Hernández-Díaz; Isela Esther Juárez-Rojop; María Lilia López-Narváez; Carlos Alfonso Tovilla-Zárate; Alma Genis-Mendoza; Mariela Alpuin-Reyes
Journal:  Behav Brain Funct       Date:  2016-11-09       Impact factor: 3.759

9.  Verbal memory improvement in first-episode psychosis APOE-ε4 carriers: a pleiotropic effect?

Authors:  Fidel Vila-Rodriguez; Donna J Lang; Heather Baitz; Kristina Gicas; Allen E Thorton; Thomas S Ehmann; Geoff N Smith; Alasdair M Barr; Ivan J Torres; Lili C Kopala; G William MacEwan; Daniel J Müller; James L Kennedy; William G Honer
Journal:  Neuropsychiatr Dis Treat       Date:  2017-12-08       Impact factor: 2.570

10.  Association between cognitive impairment and apolipoprotein A1 or apolipoprotein B levels is regulated by apolipoprotein E variant rs429358 in patients with chronic schizophrenia.

Authors:  Wenwang Rao; Yunshu Zhang; Keqing Li; Xiang Yang Zhang
Journal:  Aging (Albany NY)       Date:  2021-06-16       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.